Latest News and Press Releases

Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American...

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- A global movement with a decade of impact! This year, Movember and The Distinguished Gentleman’s Ride (DGR) proudly mark 10 years of partnership,...

Swissmedic grants marketing authorization for PYLCLARI® in Switzerland b.e. Imaging is marketing authorization holder and has exclusive distribution rights for PYLCLARI® across Switzerland ZURICH,...

NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal...

New York, USA, May 05, 2025 (GLOBE NEWSWIRE) -- Prostate Cancer Types Market Set for Robust Growth Through 2034, Driven by Advances in Targeted Therapies and Biomarker | DelveInsight The prostate...

Dublin, May 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Indication, Clinical Application, End User and Country-Level Analysis...

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...

Koelis announces partnership with Bot Image™ to bring AI-powered precision to prostate biopsy—see the breakthrough at AUA 2025 in Las Vegas at Booth #1259.

GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...

Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan...